Study on dapagliflozin for heart health after a hypertensive pregnancy
Treatments studied
Part of Heart & circulation, Women’s health & pregnancy clinical trials.
This trial tests a medicine called dapagliflozin (DAPA) to see if it reduces heart risk in women who had high blood pressure or preeclampsia during pregnancy. It is designed for those who had severe blood pressure rises around delivery or a high BNP level, a marker of heart strain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You delivered at the University of Michigan or enrolled in their postpartum blood pressure program.
- You were at least 23 weeks pregnant at delivery.
- You had a diagnosis of high blood pressure or a hypertensive disorder like preeclampsia during pregnancy.
- You had two or more blood pressure readings of 160/110 or above at least 1 hour apart, or a high heart-strain marker (BNP) within 12 hours of delivery.
- You agree to use a planned birth control method during the trial.
- You do not plan to get pregnant in the next 8 months and will not be breastfeeding after enrollment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether dapagliflozin can improve tiny blood-vessel function in women who have heart-ache-like symptoms but no major blockage on heart scans. If it works, it may help symptoms related to “microvascular” heart circulation problems.
This trial tests if combining baxdrostat with dapagliflozin helps protect kidney function and reduce heart risks in people with chronic kidney disease and high blood pressure. It's for adults who are already taking standard blood pressure medications.
This trial tests whether a diabetes drug called dapagliflozin (also used for heart failure) can help people recover better after a recent heart attack. It's for adults who are already on standard blood thinners and have had a heart attack in the past week.
This trial studies whether dapagliflozin (the medicine in Trudapa tabs) is safe and works in people who have both type 2 diabetes and high blood pressure. It may help control blood sugar and blood pressure, while researchers closely watch for side effects.
This study tests if the drug dapagliflozin (a medicine that helps protect the heart and kidneys) can improve recovery in patients who needed a breathing machine or blood pressure support in the ICU. If you qualify, you would take the drug after leaving the ICU to see if it lowers the risk of heart or kidney problems.
This trial studies dapagliflozin, a diabetes medicine, to see if it can help people with paroxysmal atrial fibrillation (irregular heart rhythm). If you have both diabetes and this type of AF, the study may offer a chance to improve your heart rhythm and outcomes.
Hear when a new Gestational Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.